209
Views
42
CrossRef citations to date
0
Altmetric
Review

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®

, &
Pages 1561-1572 | Published online: 18 Aug 2016

References

  • LaubeBLThe expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an updateTransl Respir Med20142325505695
  • LavoriniFInhaled drug delivery in the hands of the patientJ Aerosol Med Pulm Drug Deliv201427641441825238005
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2015 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed 22 July 2016
  • Global Initiative for Asthma (GINA)Global Strategy for Asthma Management and Prevention Available from: http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed July 22 2016
  • LavoriniFFontanaGAUsmaniOSNew inhaler devices – the good, the bad and the uglyRespiration201488131524902629
  • RamseySDSuboptimal medical therapy in COPD: exploring the causes and consequencesChest20001172 Suppl33S37S10673472
  • PriceDFletcherMvan der MolenTAsthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) surveyNPJ Prim Care Respir Med2014241400924921985
  • LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
  • PriceDBosnic-AnticevichSBriggsAInhaler competence in asthma: common errors, barriers to use and recommended solutionsRespir Med20131071374623098685
  • RauJLPractical problems with aerosol therapy in COPDRespir Care200651215817216441960
  • SanduzziABalboPCandoliPCOPD: adherence to therapyMultidiscip Respir Med2014916025485108
  • DekhuijzenPNVinckenWVirchowJCPrescription of inhalers in asthma and COPD: towards a rational, rapid and effective approachRespir Med2013107121817182124120398
  • PapiAHaughneyJVirchowJCRocheNPalkonenSPriceDInhaler devices for asthma: a call for action in a neglected fieldEur Respir J201137598298521532013
  • DekhuijzenPNBjermerLLavoriniFNinaneVMolimardMHaughneyJGuidance on handheld inhalers in asthma and COPD guidelinesRespir Med2014108569470024636812
  • CromptonGKBarnesPJBroedersMThe need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement TeamRespir Med200610091479149416495040
  • FinkJBRubinBKProblems with inhaler use: a call for improved clinician and patient educationRespir Care200550101360137416185371
  • Lee-WongMMayoPHResults of a programme to improve house staff use of metered dose inhalers and spacersPostgrad Med J20037993022122512743342
  • PressVGPincavageATPappalardoAAThe Chicago Breathe Project: a regional approach to improving education on asthma inhalers for resident physicians and minority patientsJ Natl Med Assoc2010102754855520690317
  • SelfTHArnoldLBCzosnowskiLMSwansonJMSwansonHInadequate skill of healthcare professionals in using asthma inhalation devicesJ Asthma200744859359817943567
  • DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
  • IbrahimMVermaRGarcia-ContrerasLInhalation drug delivery devices: technology updateMed Devices (Auckl)2015813113925709510
  • LavoriniFThe challenge of delivering therapeutic aerosols to asthma patientsISRN Allergy2013201310241823984095
  • LeachCLDavidsonPJBoudreauRJImproved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasoneEur Respir J1998126134613539877489
  • LabirisNRDolovichMBPulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsBr J Clin Pharmacol200356660061214616419
  • AcerbiDBrambillaGKottakisIAdvances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technologyPulm Pharmacol Ther200720329030316890465
  • UsmaniOSBiddiscombeMFBarnesPJRegional lung deposition and bronchodilator response as a function of beta2-agonist particle sizeAm J Respir Crit Care Med2005172121497150416192448
  • UsmaniOSTreating the small airwaysRespiration201284644145323154684
  • AriAFinkJBGuidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapyExpert Rev Respir Med20115456157221859275
  • JuliusSMShermanJMHendelesLAccuracy of three electronic monitors for metered-dose inhalersChest2002121387187611888975
  • VinckenWDekhuijzenPRBarnesPThe ADMIT series – issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPDPrim Care Respir J2010191102019890594
  • VoshaarTSpinolaMLinnanePComparing usability of NEXThaler® with other inhaled corticosteroid/long-acting beta2-agonist fixed combination dry powder inhalers in asthma patientsJ Aerosol Med Pulm Drug Deliv201427536337024299501
  • AndersonPUse of Respimat Soft Mist inhaler in COPD patientsInt J Chron Obstruct Pulmon Dis20061325125918046862
  • PitcairnGReaderSPaviaDNewmanSDeposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhalerJ Aerosol Med200518326427216181001
  • PriceDChrystynHKaplanAEffectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary careAllergy Asthma Immunol Res20124418419122754711
  • HodderRPriceDPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerInt J Chron Obstruct Pulmon Dis2009438139019888356
  • VirchowJCWhat plays a role in the choice of inhaler device for asthma therapy?Curr Med Res Opin200521Suppl 4S19S2516138941
  • MelaniASInhalatory therapy training: a priority challenge for the physicianActa Biomed200778323324518330086
  • DalbyRNEicherJZierenbergBDevelopment of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disordersMed Devices (Auckl)2011414515522915941
  • ChodoshSFlandersJSKestenSSerbyCWHochrainerDWitekTJJrEffective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severityJ Aerosol Med200114330931511693842
  • ScichiloneNSpataforaMBattagliaSArrigoRBenfanteABelliaVLung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulationsJ Asthma Allergy20136112123378776
  • AsakuraYNishimuraNMaezawaKTerajimaTKizuJChohnabayashiNEffect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devicesJ Aerosol Med Pulm Drug Deliv2013261414522691112
  • NaveRMuellerHFrom inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroidsInt J Gen Med201369910723516175
  • JacksonCLipworthBOptimizing inhaled drug delivery in patients with asthmaBr J Gen Pract1995454016836878745869
  • WeersJGBellJChanHKPulmonary formulations: what remains to be done?J Aerosol Med Pulm Drug Deliv201023Suppl 2S5S2321133800
  • BorovinaLRTremellenKEWalkerMPThe microbial contamination of pressurised metered-dose inhalers anonymously sourced from the South-East Queensland Australia community populationInt J Pharm Pract201220212913322416937
  • de VriesTWRottierBLVissermanHWilffertBWeelJThe influence of inhaled corticosteroids and spacer devices on the growth of respiratory pathogenic microorganismsAm J Infect Control200937323724018922602
  • LenneyJInnesJACromptonGKInappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICIRespir Med200094549650010868714
  • HodderRReesePRSlatonTAsthma patients prefer Respimat Soft Mist Inhaler to TurbuhalerInt J Chron Obstruct Pulmon Dis2009422523219554196
  • FreytagFRau-BergerHGlaabTWolfKRespimat® Soft Mist™ inhaler preferred to Diskus by patients with COPD and/or asthma [abstract]Am J Respir Crit Care Med2007175639
  • ChoraoPPereiraAMFonsecaJAInhaler devices in asthma and COPD – an assessment of inhaler technique and patient preferencesRespir Med2014108796897524873873
  • MolimardMColthorpePInhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitionersJ Aerosol Med Pulm Drug Deliv201528321922825265316
  • MooreACStoneSMeeting the needs of patients with COPD: patients’ preference for the Diskus inhaler compared with the HandihalerInt J Clin Pract200458544445015206499
  • SantusPPiccioloSProiettoADoctor-patient relationship: a resource to improve respiratory diseases managementEur J Intern Med201223544244622726373
  • SchurmannWSchmidtmannSMoroniPMasseyDQidanMRespimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfactionTreat Respir Med200541536115725050
  • HanadaSWadaSOhnoTSawaguchiHMurakiMTohdaYQuestionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchInt J Chron Obstruct Pulmon Dis201510697725609941
  • MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
  • MelaniASBonaviaMCilentiVInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
  • Boehringer Ingelheim LtdSPIRIVA® HandiHaler® Summary of Product CharacteristicsBoehringer Ingelheim Ltd Available from: http://www.medicines.org.uk/emc/medicine/10039/SPC/Accessed 2012
  • Boehringer Ingelheim Pharma GmbH & Co. KGSummary of Product Characteristics – SPIRIVA® Respimat® 2.5 Microgram, Inhalation SolutionIngelheim, GermanyBoehringer Ingelheim Pharma GmbH & Co. KG2013 Available from: http://products.boehringer-ingelheim.com/products/prescription_medicines/respiratory/copd/spiolto/public/assets/spiriva_respimat_spc_published.pdfAccessed 2014
  • NewmanSImproving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug deliveryExpert Opin Drug Deliv201411336537824386924
  • NewmanSPInhaler treatment options in COPDEur Respir Rev200514102108